Vanguard Group Inc. reduced its position in shares of Herbalife Ltd. (NYSE:HLF – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,261,079 shares of the company’s stock after selling 300,700 shares during the period. Vanguard Group Inc. owned 10.34% of Herbalife worth $156,584,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Goldman Sachs Group Inc. grew its position in shares of Herbalife by 164.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,288,198 shares of the company’s stock valued at $19,658,000 after purchasing an additional 801,644 shares during the last quarter. Readystate Asset Management LP grew its holdings in Herbalife by 136.7% in the 4th quarter. Readystate Asset Management LP now owns 132,505 shares of the company’s stock valued at $2,022,000 after buying an additional 76,514 shares during the last quarter. GSA Capital Partners LLP grew its holdings in Herbalife by 523.6% in the 4th quarter. GSA Capital Partners LLP now owns 177,281 shares of the company’s stock valued at $2,705,000 after buying an additional 148,851 shares during the last quarter. Hotchkis & Wiley Capital Management LLC increased its position in Herbalife by 7.7% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 1,624,370 shares of the company’s stock worth $24,788,000 after buying an additional 116,030 shares during the period. Finally, Armistice Capital LLC acquired a new position in shares of Herbalife during the fourth quarter worth approximately $5,799,000.
Herbalife Stock Performance
Shares of Herbalife stock opened at $11.36 on Friday. The firm has a market cap of $1.14 billion, a P/E ratio of 8.29 and a beta of 1.25. The firm’s 50-day simple moving average is $10.69 and its 200-day simple moving average is $10.76. Herbalife Ltd. has a twelve month low of $6.68 and a twelve month high of $19.48.
Insider Buying and Selling at Herbalife
In related news, Director Donal L. Mulligan acquired 30,000 shares of the business’s stock in a transaction on Friday, May 3rd. The stock was bought at an average cost of $9.65 per share, with a total value of $289,500.00. Following the completion of the acquisition, the director now owns 60,000 shares in the company, valued at $579,000. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, Director Donal L. Mulligan acquired 30,000 shares of the company’s stock in a transaction dated Friday, May 3rd. The stock was bought at an average price of $9.65 per share, with a total value of $289,500.00. Following the completion of the acquisition, the director now owns 60,000 shares in the company, valued at approximately $579,000. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Juan Miguel Mendoza bought 2,500 shares of Herbalife stock in a transaction dated Wednesday, May 8th. The stock was acquired at an average cost of $10.17 per share, for a total transaction of $25,425.00. Following the completion of the acquisition, the director now directly owns 80,779 shares in the company, valued at $821,522.43. The disclosure for this purchase can be found here. Insiders have purchased 42,500 shares of company stock worth $418,485 over the last three months. Company insiders own 0.94% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently issued reports on HLF. Mizuho raised their price objective on shares of Herbalife from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Friday, June 7th. DA Davidson restated a “neutral” rating and set a $9.50 price objective on shares of Herbalife in a report on Thursday, May 2nd. Bank of America cut their price objective on shares of Herbalife from $10.00 to $8.00 and set an “underperform” rating for the company in a research report on Thursday, March 21st. Finally, StockNews.com raised Herbalife from a “hold” rating to a “buy” rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $10.70.
Read Our Latest Stock Report on HLF
Herbalife Profile
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Stories
- Five stocks we like better than Herbalife
- How to Start Investing in Real Estate
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- P/E Ratio Calculation: How to Assess Stocks
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.